HOMI BHABHA CANCER HOSPITAL & RESEARCH CENTRE MUZAFFARPUR
(Unit of Tata Memorial Centre, Mumbai)
A Grant-In-Aid Institute of The Department of Atomic Energy Government Of India
Homi Bhabha Cancer Hospital and Research Centre (HBCH & RC), Uma Nagar, Rasulpur, SKMCH Campus, Bihar 842004, is a Grant in Aid institutions under the Department of Atomic Energy, GOI. As the newest member institutions of the Tata Memorial Centre (TMC), it is dedicated to the ethos of pioneering affordable cancer care in India, specifically in North Bihar region. The entire region has limited health care infrastructure and quality cancer care is not within the reach of the common populace. With the rising cancer incidence in India, the most conservative estimates also pitch a mind boggling figures of more than 15,00,000 new cancer cases by the year 2025. The proposed catchment areas are Bihar, eastern Uttar Pradesh, Jharkhand, West Bengal, and, even, neighbouring countries like Nepal, and Bhutan. These include many of the most socio-economically backward areas of India. The proposed state-of art 100 bed hospital will serve as a ‘spoke’ of the Hub-and Spoke model of cancer care pioneered by TMC with the ‘hub’ being our larger centres in Mumbai and Varanasi. As a part of the support from the Bihar state government 15 acres of land within the premises of Sri Krishna Medical College & Hospital (SKMCH) have been allotted for the construction of this hospital. Heeding to the urgent need of providing services, a temporary modular hospital has been commissioned. This facility will provide advanced cancer diagnostics, treatment of solid as well as haematological malignancies.
The Tata Memorial Center Grant-in-aid institute under the Department of Atomic Energy (DAE) Govt. of India that has established 8 new peripheral cancer hospitals to cater to the needs of Cancer Patients and Strengthen Cancer Care Services across India. DAE has approved establishment of Homi Bhabha Cancer Hospital & Research Centre (HBCH&RC) at Muzaffarpur District of Bihar in support with Bihar Government. Currently HBCH&RC started functioning by the space provided by Govt. of Bihar to run the Cancer OPD, Surgical services, Chemotherapy, Telemedicine, Palliative Care and Population Based Cancer Registry (PBCR) Program.
Shri. Honorable Minister Health, Art Culture, Youth and Road Construction Department, Bihar has informed REC that Government of Bihar has decided to scale up the Cancer Screening Program in 14 districts of Bihar.
RECF, under its CSR activities sanctioned its financial contribution for Strengthening Cancer Screening and Awareness Programme of Basic Cancer Care Services in 14 Districts of Bihar namely: - Muzaffarpur, Vaishali, Samastipur, Siwan, Darbhanga, Madhubani, Supaul, Bhagalpur, Begusarai, Bhojpur, Patna, Nalanda, Gaya, Aurangabad.
Brief About Muzaffarpur Project
HBCH&RC, Muzaffarpur in association with Health Department, Govt. of Bihar propose to work on long term basis to strengthen the Comprehensive Cancer Care Services in Bihar right from Community level awareness to Cancer Screening & early detection, Chemotherapy, Radiotherapy, Onco-surgical and Home-based Palliative care services. In the first 3 years we will focus on strengthening Community Awareness, Screening & Early detection, Activation of Dental clinics for Oral cancer screening, increasing availability of Tablet Morphine for Palliative care needs and strengthening PHC, CHC & DH to conduct Cervical cancer screening program apart from Oral and Breast cancer screening in all 14 districts of Bihar. Training and Capacity building of existing Doctors, Healthcare workers under Bihar govt. at district & block level health facilities for Oral, Breast & Cervical Cancer Screening.
Homi Bhabha Cancer Hospital & Research Centre will also help in Alignment, Supportive supervision, Handholding- mentoring of 4 key National programs “National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS), National Tobacco Control Program (NTCP), National Oral Health Program (NOHP) & National Program for Palliative Care (NPPC) in the Targeted Districts in phased manner for greater synergy, sustainability and impact on ground. HBCH&RC team will coordinate with NHM Bihar Office and all the activities performed under these headings will be reported to respective State Project Officers (SPO) & Nodal officers at District level of these 4 programs in the required reporting formats
Brief About Cancer Screening Program
A well planned Oral, Breast and Cervical cancer screening at the community level screening and early detection program can help in down staging of cancers from current 60-70% stage III/IV cancers to Stage I/II over 7 to 10 yrs. period. We have a dedicated team for Community Based Cancer Screening Program, so that we can pick up early-stage Common Cancers, we have started the program in 14 Districts (8 from North Bihar and 6 from South Bihar) considering high burden of cancers in these districts as well as in the vicinity of medical college within 100Km radius for referral of suspected cases and further examination.
OPD timings • Monday – Friday (9am to 5pm) • Saturday – 9am – 1 pm
About us
Cancer is considered a systemic disease, so most patients registered at HBCH&RC, Muzaffarpur are seen by the Department of Medical Oncology, which deals with systemic therapies such as chemotherapy. The department is committed to providing efficient care and insights into research for both adult and pediatric cancer patients.
The services provided by the department include:
He has completed his MD from VMMC and Safdarjung Hospital, New Delhi and DM in Medical oncology from Tata Memorial Hospital, Mumbai. Dr Gunjesh has a vast experience in the field of oncology including adult solid (breast, lung, head and neck, gastrointestinal, gynecological, urogenital and bone/soft tissue) malignancies, as well as adult hematological cancers. He provides specialized and multidisciplinary approach for the treatment of aforesaid cancers. The lines of treatment include chemotherapy, hormone therapy, immunotherapy, targeted therapy and monoclonal antibody therapy
He has multiple publications in various international and Indian indexed journals. Dr Gunjesh has also presented his award-winning researches in various international platforms such as American society of clinical oncology (ASCO) and European society for medical oncology (ESMO).
He has been awarded with Dr Kalla Venkat Young Researcher award by Indian society of Medical and Pediatric Oncology (ISMPO) in 2019.
About us
Department of Surgical Oncology is the state-of-the-art department offering surgical services for all solid tumors. The department provides clinical care for different sub specialties like Head & Neck, Gastrointestinal, Breast, Bone & Soft tissue, Urology and Gynecologic Oncology. At the heart of a state-of-the-art surgical oncology department lies its unwavering commitment to patient-centric care. Every aspect of the department is designed to prioritize the well-being and comfort of the patients. The department focuses on creating a supportive and compassionate environment, providing personalized care plans tailored to each patient's unique needs. Patient education, emotional support and shared decision-making are integral components of the department's approach, ensuring that patients are actively involved in their treatment journey.
The services provided by the department include:
Dr Burhanuddin is a young motivated head and neck surgeon with fellowships in head and neck surgical oncology after masters training in oral and maxillofacial surgery. He has worked at Tata Memorial Hospital, Mumbai as a Surgical fellow and also as research fellow for five years. He has been actively involved in exclusive surgical management, teaching, research and auditing of head and neck cancer during his training at the Tata Memorial Hospital, Mumbai.
Breast and uro-oncology surgery – Team of surgeons from Mumbai and Varanasi come on regular basis for surgery of carcinoma breast and uro-oncology.
Report on Pathology department
Three divisions make up the Pathology department and they work in unison with well-established academic practices that are the hallmark of TMH, Mumbai.
She has completed her MD pathology from VMMC and Safdarjung Hospital, New Delhi. She has an experience of about 5 years in her field. Currently she is working as Senior Resident in the department of onco-pathology in Tata Memorial Centre, Mumbai. She has expertise in histopathology, cytopathology, hematology and immunohistochemistry with special interest in onco-pathology. She has various research publications in international and Indian indexed journals.
Our onco-pathology labs is well equipped and currently we are processing all tissues and fluids for diagnosis. We will have our inhouse IHC and hematology (flowcytometry) facility in future.
Services offered include histopathology, Immunohistochemistry and cytopathology.
The histopathology division is equipped with grossing station, electrical bone saw, bone decalcified, automated tissue processor, slide-stainer and Ventana immunostainer and Cyto-centrifuge.
Pathologists and staff members are periodically sent for training to Mahamana Pandit Madan Mohan Malaviya Cancer Centre (MPMMCC), Varanasi.
Head & neck, breast, female genital tract, GI & hepatobiliary cancers and lymphomas and pediatric tumors constitute the bulk of the service load.
Surgical specimens are grossed and reported synoptically per TMH and CAP protocol so that they are meaningful from the point of view of therapy in accordance with standard protocols. There is emphasis on maintaining the turnaround time (TAT) so that patients do not suffer.
Like histopathology, cytopathology too, is reported per standard recommendations.
Postgraduate students from SKMCH are posted to the department for academic training. This is aided by discussion on the multi-head microscope.
The histopathology division, along with the NGS facility, is part of an ICMR-funded study on oral cancer.
Though it is early days for all, this is especially true of the hematology division. Routine hematology, including CBC and coagulation studies, has recently been augmented with cytochemical testing for leukemia’s. Lab technologists who have been trained at HBCH, Varanasi, ensure that TAT is adhered to, and QC procedures are followed. Purchase of new equipment that would strengthen the division has been initiated. Even without them, however, leukemia cases are reported very fast on morphology, an exercise that represents the best use of what we currently have. Their accuracy and the constant dialog with the treating physicians ensures that therapeutic decisions can be initiated early, and lives saved. Special processing of leukemia samples so that they can be later taken up for molecular studies is under way. Residents, including junior residents from SKMH receive the best training here.
Aside from routine parameters, this lab offers immunoassay and tumor marker services and serum and urine osmolality. Two senior Scientific Officers, trained in MPMMCC, Varanasi and HBCHRC, Mullanpur, Punjab, manage the services including quality control, both internal and external. Serum methotrexate level testing is soon to be started.
All in all, a department set to become the best, like all units of the parent institution TMH, Mumbai
Introduction: A molecular testing facility was established on July 2022 and initiated from November 2022 at Homi Bhabha Cancer Hospital & Research Centre (HBCHRC), Muzaffarpur, Bihar with the aim to provide molecular diagnostic service to patient as well as to develop clinical cancer research.
Purpose of the lab: Different molecular testing is ongoing. Purpose of these testing is to identify the genetic abnormalities driving the cancer of patients. If the detected abnormality has the available FDA-approved drug, then this type of treatment will provide better survival benefit of that patient compared to conventional anti-neoplastic drugs. Thus, the identified genetic alterations can provide valuable insights into the detection of the cause and behavior of the cancer, helping the oncologists to tailor treatment plans to individual patients.
About each test: Details of each testing are given below:
a) Next generation sequencing (NGS) of solid tumor and hereditary cancer -
A targeted panel of 72 genes with diagnostic, prognostic and therapeutic importance in solid tumor is currently used on Illumina platform to detect four different types of genetic abnormalities –single nucleotide variants (SNVs), fusion, insertion-deletion and copy number alterations.
b) Mutation detection at single gene by RT-PCR method
Quantitative Real time- PCR based detection of genetic alterations of EGFR gene (test code F335), DPYD gene (code F336), BRAF gene (code F685), RAS isoforms (code F682) are ongoing.
1525 tissue and blood in pair have been collected and stored with proper annotation.
Clinical Research has multiple studies
About Us
The discipline of Clinical Biochemistry is an area in Chemistry, concerned with the analysis and diagnosis of various pathological conditions forming a way across patients and clinicians. This Laboratory at HBCH&RC became operational on the 21st Feb 2022. The lab is equipped with high throughput state of art auto-analyzers. The labs have been participating in internal and external quality assurance programs.
Department offers various laboratory services like clinical biochemistry, tumors markers and immunoassay. We have an extensive test menu of more than 100 assays. During the period 01.01.2023 to 31.12.2023, the laboratory performed 2,74,565 routine biochemistry tests on an average TAT of 03 hours and for emergency within 02 Hours along with 5,681 tumor markers and immunoassay. Department provides 13x7 (7AM - 8PM) laboratory services. We are further working towards the establishment of the special investigations like therapeutic drug monitoring services by HPLC and myeloma test services. The department is under the process of NABL accreditation.0
The lab supports research and educational activities for the development and growth of employees.
Microbiology is essentially a response to clinical needs. Its importance lies in the form of diagnostic and therapeutic guidance.
The main functions of Microbiology lab in the hospital is in diagnosis of infection in individual patient and the other is to contribute in HAI prevention and control.
In near future, we are look forward to extend our services by initiating new tests at our center which is even more going to help in the timely and appropriate treatment of our patients.
Following are test offered in microbiology lab to cater the cancer patients in HBCH&RC, Muzaffarpur.
S. No. | Name of Tests | |
---|---|---|
1 | Aerobic culture/sensitivity |
|
2 | Automated blood culture |
|
3 | Automated Identification & Antibiotic Susceptibility Testing Vitek |
|
4 | Staining for Cryptosporidium spp. |
|
5 | Urine Examination |
|
6 | Stool Examination |
|
7 | Stool for Clostridium Difficile |
|
8 | Occult Blood |
|
9 | Ziehl Neelsen AFB Stain |
|
10 | Mantoux Test |
|
11 |
|
|
12 | Detection of MDR/XDR of M.tb |
|
13 | KOH Mount |
|
14 | Automated Fungal culture/ sensitivity |
|
15 | Hepatitis B Surface Antigen Test(HBsAg) |
|
16 | Anti- Hepatitis C antibody (Anti HCV) |
|
17 | Human Immunodeficiency Virus(Antigen &Antibody) HIV |
|
18 | Dengue IgG-IgM antibody &NS-1 Antigen |
|
19 | Malaria Antigen Test |
|
20 | Procalcitonin Level(Semi Quantitative assay) |
|
21 | ||
22 | True NAT HPV DNA |
|
23 | Antigen detection of virus in Stool (i.e. Rotavirus+ Adenovirus + Astrovirus + Norovirus) |
|
24 | CARBA-R test by Gene Xpert |
Dr Ravikant has done his MBBS and MD (PSM) from Seth GSMC & KEM Hospital, Mumbai and currently working as Assistant professor Tata Memorial Centre, Mumbai under Department of Atomic Energy, Govt. of India since Nov 2019. He has founded Non-Profit Organisation “DOCTORS FOR YOU” in 2007. His work in public health sector workforce development for emergency response and multi drug resistance Tuberculosis in India is impeccable. Dr Ravikant is a member of Asian Disaster Reduction & Response Network (ADRRN). He is the first & only Indian to receive South Asian Association for Regional Corporation (SAARC) award for outstanding work in the aftermath of disasters in 2010.
She has completed her MBBS from RIMS, Ranchi and MS in obstetrics and gynecology from VMMC & Safdarjung Hospital, New Delhi and served as a senior resident for three years at Safdarjung Hospital. Worked as Assistant Professor at Sikkim Manipal Institute of Medical Sciences for three years and currently Heading Onco Gynec Unit at Homi Bhabha Cancer Hospital and Research centre, Muzaffarpur, Bihar. She is also leading the Cervical Cancer Screening & Early Detection Program in 14 Districts of Bihar and has multiple publications to her credit. She has done Sai Niwas health care colposcopy and preventive oncology course in October 2020.
Designation: Palliative Care, HBCH&RC, Muzaffarpur
She has ompleted MBBS and MD (Biochemistry) from JNMC, Aligarh. After completing her Senior Resident-ship from G B Pant PGIMER/MAMC, New Delhi she worked as Assistant Professor in Lady Hardinge Medical College, New Delhi and headed Biochemistry department at Balco Medical Centre, Raipur a tertiary cancer care centre from where Inspired by her mentor she moved to BBCI/TMH Guwahati and IPM Kozhikode for her fellowship in Palliative Medicine and has worked as Cipla's Home-based Palliative Care Physician. She has secured QI cohort status for TMH Muzaffarpur being run by Stanford India Quality Improvement Program 2021 as the Clinical Lead. She is working as an honorary Consultant of Palliative Medicine in TMH Muzaffarpur, Bihar. She will be taking forward the Palliative Care Program in 14 districts of Bihar on lines of the National Program for Palliative Care (NPPC)
Department of Pain and Palliative Medicine plays a pivotal role in providing support to terminally ill cancer patients and their families, to improve the quality of life and alleviate the sufferings. We have both adult, geriatric, adolescent & Paediatric palliative care services, which has eventually become now the tertiary referral centre for part of entire Northern and Central Northern India. We also provide home based palliative care services and community based outreach Programme. OPD services include dedicated Comprehensive Pain clinic (availability of all transdermal, subcutaneous, oral, sublingual preparations of narcotics, subcutaneous syringe drivers for Interventional Pain management), Lymphoedema clinic (decompressive and manual massage therapy), Wound and stoma clinic (availability of all hydrogel, hydrocolloid and alginate dressing). Bereavement clinic (complicated grief, major depression), Geriatric and frailty clinic (dementia, frailty). Paediatric and Adolescent Palliative Medicine Department (HBCH campus) has dedicated OPD and IPD services. Teleconsultation based home care has been running successfully for 3 years that enrolled over thousands terminally ill cancer patients those are out stationed. We are doing research in palliative medicine jointly with many reputed institutions nationally and internationally. We also conduct regular CMEs, workshops for doctors, nurses, clinical psychologists, medical social workers, volunteers and KEVATs.
General dental services which include dental extractions, restorations, sharp tooth filing to prevent trauma to the oral soft tissues.
Services Offered
The Department provides care to Bihar and nearby states. Every kind of childhood cancers is treated on-site with surgery, radiation and chemotherapy as appropriate with acute leukemias making up a significant proportion of cases. We treat all pediatric solid tumors and have a dedicated pediatric oncology surgeon and orthopedic oncologist available on site, but brain tumors are rarely seen as we lack an on-site neurosurgeon.
Online Service ( e-Medical Records - EMR ).
Muzaffarpur cancer registry is the first population-based cancer registry in the Bihar state. This registry was started in October 2018 and is located at the Sri Krishna Medical College, Muzaffarpur. It covers the population of 2.1 million. The major sources of cancer registry data are SKMCH Muzaffarpur, Mahaveer Cancer Sansthan Patna, Indira Gandhi Institute of Medical Sciences Patna, and PMCH Patna. Oral cancer is the predominant cancer in males in this area. Breast, Cervix and Gall bladder are the leading cancer sites in females.
This vision Cancer Clinic at Buxar started at District Hospital Buxar on 20th February 2020 by Hon’ble Minister of state for Health & Family Welfare Shri Ashwini Kumar Choubey and Deputy Director Center for Cancer Epidemiology (CCE), Navi Mumbai. This clinic was established with the support of CSR funds from Alkem foundation. The project is running well in full coordination with District NCD cell under NPCDCS program.
Hospital Number: 9472376989, 06212232031, 06212232032
Homi Bhabha Cancer Hospital and Research Centre (HBCH & RC), Uma Nagar, Rasulpur, SKMCH Campus, Bihar 842004,, India
Email-id: complaint@hbchrcmzp.tmc.gov.in
Website: https://tmc.gov.in/tmh/index.php/en/hbch-muzaffarpur
As HBCH, Muzaffarpur is a very young organisation research activity is yet to start in full scale..
IMPORTANT STUDIES @ HBCHRC Muzaffarpur BIHAR
Sr. No. |
Title |
Status |
Type of study |
---|---|---|---|
1.
|
TRIDENT- a randomized study of neo-adjuvant systemic therapy in oral cavity cancer.
|
Ongoing |
RCT |
2. |
Borderline resectable- phase 3 study comparing TPF versus paclitaxel-carboplatin and oral metronomic chemotherapy as neoadjuvant chemotherapy for borderline resectable oral cancers. |
Ongoing | RCT |
3.
|
Phoenix- phase 4 trial evaluating the 2 standard palliative chemotherapy regimens of PC versus PCM in advanced head and neck cancer. |
Ongoing | RCT |
4.
|
Phase 3 randomized study for evaluation of physician choice of treatment and triple metronomic as second line therapy in head and neck cancer. |
Completed | RCT |
5.
|
A phase 3 study of CCNU versus CCNU plus mebendazole in glioma |
Ongoing | RCT |
6.
|
Technical validation of liquid biopsy for solid tumors |
Ongoing | Prospective study |
7.
|
Prospective observational study to assess the pattern of care of patients treated in rural cancer center |
Completed, awaiting publication | Prospective study |
8.
|
Identification of genetic predictors responsible for local failure in margin-negative oral squamous cell carcinoma patients in India |
Ongoing | Prospective study |
9.
|
Barriers and mapping of RAI therapy in India. |
Ongoing, awaiting IEC Approval | Observational Study |
10.
|
Incidence of OSCC in operated with negative HPR consent. |
Ongoing, awaiting IEC Approval | Prospective study |
11.
|
IHC in CUPS |
Ongoing, awaiting IEC Approval | Observational |
12.
|
IHC in salivary gland tumors. |
Completed | Review |
13.
|
CfDNA in high risk oral cancer for deciding adjuvant treatment |
Ongoing, awaiting IEC Approval | Prospective study |
14.
|
Cancer caregiver support system – a randomized control trial to assess the effect of improved caregiver support on post-operative recovery of head and neck cancer patients. |
Ongoing | RCT |
15.
|
Optimizing surgical margins without frozen section – a retrospective audit. |
Completed, awaiting publication | Retrospective |
16.
|
Linguistic translation and validation of the Bluebelle wound healing questionnaire (WHQ) in Hindi |
Ongoing | Prospective |
17.
|
Neo-adjuvant chemotherapy for functional preservation of the hypoglossal nerve in advanced cancers of the oral tongue. |
Protocol development | RCT |
18.
|
Prospective longitudinal study to assess ctDNA using NGS in advanced oral cancer patients. |
Ongoing | Prospective |
19.
|
Retrospective audit of payment delivery models and associated delay in adjuvant therapy in patients undergoing oral cancer surgery at a tertiary cancer center in Bihar. |
Ongoing | Retrospective |
20.
|
Validation of Bethesda and Milan staging in thyroid and salivary gland malignancies. |
Proposed | Retrospective |
21.
|
Psychosocial outcomes following oral cancer surgery and reconstruction with PMMC flap. |
Proposed | Prospective |
22.
|
Study on factor causing delay in delivery of therapeutic and diagnostic cancer care services at District and Hospital level in state of Bihar. |
Ongoing | 2yrs Prospective Study Grant from National Health Mission |
23.
|
Improving Primary Health Care for Patients with Non-Communicable Diseases during severe flooding in India. |
Ongoing | 5yrs RCT NIHR UK grant |
24.
|
Assessment of Awarness about Cervical cancers, prevention and detection of High Risk HPV using Menstrual Pad/clot in Muzaffarpur, Bihar India |
Ongoing | Prospective |
25.
|
AMR stewardship Program |
Ongoing | Prospective Multi centric study |
26.
|
Survivorship in cervical cancer patients: a study from tertiary cancer care centre Muzaffarpur Bihar |
Ongoing | Retrospective Study |
27.
|
Profile Survivorship Pattern & Quality of service provided to cancer patients enrolled with Home Based Palliative Care Services of HBCHRC Muzaffarpur. |
Data Collection completed | Retrospective Study |
टाटा स्मारक अस्पताल
डॉ ई बोर्जेस रोड, परेल, मुंबई - 400 012 भारत
फ़ोन: +91-22- 24177000, 24146750 - 55
फैक्स: +91-22-24146937
ईमेल : msoffice@tmc.gov.in (रोगी देखभाल और प्रश्नों के लिए) / hrd@tmc.gov.in(प्रशासनिक के लिए - HRD मायने रखता है)
कॉपी राइट © 2016 टाटा स्मारक केंद्र, को है. सभी अधिकारी सुरक्षित.इस वेबसाइट को सबसे अच्छी तरह देखा जा सकता है फ़ायरफ़ॉक्स,माइक्रोसॉफ़्ट एक्सप्लोरर 9.0+, Chrome, फ़ायरफ़ॉक्स
द्वारा परिकल्पित एवं विकसित ग्लोबलअॅप
1189924 (34)